butylhydroxybutylnitrosamine has been researched along with Genetic Predisposition in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eriksson, P; Foth, M; Ismail, NFB; Iwata, T; Knowles, MA; Kung, JSC; Salmond, JM; Sansom, OJ; Sjödahl, G; Tomlinson, D | 1 |
| Gonzalgo, ML; He, Y; Hooker, E; Johnson, DT; Luong, R; Sun, Z; Yu, EJ | 1 |
| Johnson, DT; Lee, JT; Lee, SH; Lin, D; Luong, R; Peng, Y; Shaltouki, A; Sun, Z; Wang, Y | 1 |
| Akaza, H; Hattori, K; Iida, K; Itoh, K; Kawai, K; Kumagai, Y; Oyasu, R; Shimazui, T; Yamamoto, M | 1 |
| Akaza, H; Iida, K; Itoh, K; Kumagai, Y; Maher, JM; Mori, Y; Oyasu, R; Shimazui, T; Yamamoto, M | 1 |
| Baffa, R; Croce, CM; Fassan, M; Giarnieri, E; Gomella, LG; Iozzo, RV; Ishii, H; Sevignani, C; Vecchione, A | 1 |
| Arakawa, Y; Fukushima, S; Hiai, H; Higashi, S; Kamoto, T; Makino, S; Mori, S; Murai, T; Yoshida, O; Yoshitomi, M | 1 |
| Akaza, H; Asamoto, M; Matsuoka, Y; Ochiya, T; Ota, T; Sekiya, T; Terada, M; Toriyama-Baba, H; Tsuda, H; Yamamoto, F | 1 |
1 trial(s) available for butylhydroxybutylnitrosamine and Genetic Predisposition
| Article | Year |
|---|---|
Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Cell Cycle Proteins; DNA-Binding Proteins; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HEK293 Cells; Heterozygote; Humans; Male; Mice; Mice, Knockout; Prostatic Neoplasms; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 2013 |
7 other study(ies) available for butylhydroxybutylnitrosamine and Genetic Predisposition
| Article | Year |
|---|---|
FGFR3 mutation increases bladder tumourigenesis by suppressing acute inflammation.
Topics: Animals; Butylhydroxybutylnitrosamine; Cell Transformation, Neoplastic; Cholecystitis, Acute; Disease Models, Animal; Disease Progression; Female; Genetic Predisposition to Disease; Lymphocytes; Male; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neutrophil Infiltration; Neutrophils; Phenotype; Receptor, Fibroblast Growth Factor, Type 3; Time Factors; Tumor Microenvironment; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2018 |
Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice.
Topics: Androgens; Animals; Butylhydroxybutylnitrosamine; Carcinoma, Transitional Cell; Cell Division; Cell Transformation, Neoplastic; Drug Implants; Female; Genetic Predisposition to Disease; Humans; Integrases; Male; Mice; Mice, Transgenic; Neoplasms, Hormone-Dependent; Orchiectomy; Promoter Regions, Genetic; Receptors, Androgen; Recombinant Fusion Proteins; Tamoxifen; Testosterone; Transgenes; Urinary Bladder Neoplasms; Uroplakin III | 2016 |
Nrf2 is essential for the chemopreventive efficacy of oltipraz against urinary bladder carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Carcinogens; DNA-Binding Proteins; Enzyme Induction; Female; Gene Expression; Genetic Predisposition to Disease; Glucuronides; Glucuronosyltransferase; Inactivation, Metabolic; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Microsomes, Liver; NF-E2-Related Factor 2; Pyrazines; Thiones; Thiophenes; Trans-Activators; Urinary Bladder; Urinary Bladder Neoplasms | 2004 |
Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis.
Topics: Animals; Base Sequence; Butylhydroxybutylnitrosamine; Carcinogens; DNA Primers; Genetic Predisposition to Disease; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Mutation; NF-E2-Related Factor 2; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 2007 |
Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; DNA Primers; DNA-Binding Proteins; Female; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Male; Mice; Mice, Knockout; Nerve Tissue Proteins; Urinary Bladder Neoplasms | 2008 |
Host genes affecting survival period of chemically induced bladder cancer in mice.
Topics: Animals; Butylhydroxybutylnitrosamine; Chromosome Mapping; Genetic Linkage; Genetic Predisposition to Disease; Male; Mice; Mice, Inbred Strains; Microsatellite Repeats; Quantitative Trait, Heritable; Survival Analysis; Urinary Bladder Neoplasms | 1998 |
Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
Topics: Animals; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Transitional Cell; Cocarcinogenesis; Female; Genes, ras; Genetic Predisposition to Disease; Horses; Humans; Immunoblotting; Male; Mutation; Papilloma; Pregnancy; Proto-Oncogene Mas; ras Proteins; Rats; Rats, Sprague-Dawley; Transgenes; Urinary Bladder Neoplasms | 2000 |